A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets
Year: 2003
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2068953119
